Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
04/2002
04/09/2002US6369045 Phospholipase A2 inhibitors thereof and use of same in diagnosis and therapy
04/09/2002US6369036 Enhanced activity of natamycins in the form of a solution or solvate crystal form; prevents spoilage by mold in foods
04/09/2002US6369027 Osteoprotegerin
04/09/2002US6368864 Dyes and methods of reticulocyte enumeration
04/09/2002US6368863 Reagents and methods for modulating gene expression through RNA mimicry
04/09/2002US6368860 An indian species of ginseng callus line producing anthocyanin
04/09/2002US6368853 A nucleic acid encoding a polypeptide ligand; tyrosine kinase containing immunoglobulin and epidermal growth factor homolog domains; therapy and diagnosis for angiogenesis in wound healing, inflammation or tumors
04/09/2002US6368851 Method and apparatus for measuring a state variable
04/09/2002US6368846 Ectoparasite saliva proteins and apparatus to collect such proteins
04/09/2002US6368842 An isolated nucleic acid; therapy for neuroblastomas in infant brains, uterus, lung, ovary adenocarcinomas and leukocytes
04/09/2002US6368834 PCR genome walking with synthetic primer
04/09/2002US6368830 An amino acid sequence; for efficient and increased transposition in genetic engineering methods
04/09/2002US6368826 A nucleic acid sequence encoding an insulin receptor substrate; therapy and diagnosis for tumors, cellular proliferative disorders, and cancer
04/09/2002US6368817 Detection of salmonella in feces with chromogens
04/09/2002US6368815 Incubating promyelocytic cells in the presence of phorbol ester to increase phosphodiesterase expression; add a target molecule to the treated cells in culture; harvest and disrupt the cells; quantify cyclic 3'5'-adenosine monophosphate
04/09/2002US6368812 Exposing transfected cells with dna or infected rna encoding a galanin receptor and a chemical that is a possible receptor activator; measure the receptor activity in the absence and presence of the chemical with the transfected cells
04/09/2002US6368811 Syndecan interacting proteins and the use thereof
04/09/2002US6368809 E2F ubiquitination domain, and assays for inhibitors and enhancers of E2F ubiquitination
04/09/2002US6368808 A solid carrier where nucleotides are fixed by covalent bonding by a reaction of a reactive group on the carrier and a reactive group on the nucleotide using a transition metal catalyst; no blocking procedure; hydbridization;
04/09/2002US6368806 Marker assisted identification of a gene associated with a phenotypic trait
04/09/2002US6368803 Detection of nucleic acids by target-catalyzed formation
04/09/2002US6368802 A method for synthesizing rna oligonucleotides by mixing a circular single stranded template, with a nucleotide sequence complementary to the target rna oligonucleotide, and mix with polymerase enzyme and primer to create rna oligonucleotides
04/09/2002US6368801 Detection and amplification of RNA using target-mediated ligation of DNA by RNA ligase
04/09/2002US6368800 Kits for isolating biological target materials using silica magnetic particles
04/09/2002US6368799 Method to detect gene polymorphisms and monitor allelic expression employing a probe array
04/09/2002US6368798 Screening for novel bioactivities
04/09/2002US6368797 Determining the genotype at nucleotide 192 of a gene that is an indicator of an increased risk for alzheimer's disease by performing restriction enzyme digestion of an amplified product of the nucleic acid molecule
04/09/2002US6368795 An apparatus comprising a signal path, an electrically conductive transmission line, a ground element, a dielectric layer and a molecular binding layer electromagnetically coupled to the signal path
04/09/2002US6368794 A cdna encoding a polypeptide: diagnosising and monitoring cellular proliferative diseases and cancers
04/09/2002US6368793 Metabolic selection methods
04/09/2002US6368792 A polynucleotide; monitoring, diagnosing, preventing and treating diseases, tumors or metastases of the gastrointestinal tract
04/09/2002US6368791 Methods and kits for analysis of chromosomal rearrangements associated with leukemia
04/09/2002US6368789 Screening methods to identify inhibitors of telomerase activity
04/09/2002US6368787 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements
04/09/2002US6367479 Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis, and pharmaceutical compositions and kit related thereto
04/09/2002CA2103674C Methods and apparatus for improved luminescence assays
04/09/2002CA2083271C Fibrin binding domain polypeptides and uses and methods of producing same
04/09/2002CA2048842C Substituted pyrimidine derivatives, a process for the preparation thereof and the use thereof as reagents
04/06/2002CA2358239A1 Novel siglec-like gene
04/06/2002CA2358235A1 Novel siglec gene
04/04/2002WO2002027995A2 Method, system and computer program product for technical management and biocontrol of disease in animal production systems
04/04/2002WO2002027638A1 Determination of optimal local sequence alignment similarity score
04/04/2002WO2002027331A1 Assay method with the use of redox reaction
04/04/2002WO2002027327A2 Rapid profiling of the interactions between a chemical entity and proteins in a given proteome
04/04/2002WO2002027324A2 METHODS OF USE OF ALPHA-METHYLACYL-CoA RACEMASE IN HORMONE REFRACTORY AND METASTATIC PROSTATE CANCERS
04/04/2002WO2002027318A1 Methods and compositions for screening modulators of lipid kinases
04/04/2002WO2002027315A2 Compounds with a branched linker
04/04/2002WO2002027314A1 Screening method
04/04/2002WO2002027036A2 Probes, probe sets, methods and kits pertaining to the detection, identification and/or enumeration of bacteria
04/04/2002WO2002027035A2 High-throughput gene cloning and phenotypic screening
04/04/2002WO2002027034A2 Method of identifying genetic regions associated with disease and predicting responsiveness to therapeutic agents
04/04/2002WO2002027032A1 Method for equalizing band intensities on sequencing gels
04/04/2002WO2002027031A2 Methods and reagents for live-cell gene expression quantification
04/04/2002WO2002027030A1 Haplotypes of the scyb6 gene
04/04/2002WO2002027029A2 Method for determining relative abundance of nucleic acid sequences
04/04/2002WO2002027028A1 A method of determining tumor characteristics by determining abnormal copy number or expression level of lipid-associated genes
04/04/2002WO2002027027A2 Method of screening for therapeutics for infectious diseases
04/04/2002WO2002027026A2 Improved support for solid phase hybridization assays
04/04/2002WO2002027025A2 Application of bioinformatics for direct study of unculturable microorganisms
04/04/2002WO2002027023A2 Genetic determinants for dermal inflammation and immunity
04/04/2002WO2002027022A2 Methods for diagnosing and treating autosomal dominant optic atrophy
04/04/2002WO2002027021A2 Method for detecting fungal infections
04/04/2002WO2002027020A1 Method and kit for detecting membrane protein - protein interactions
04/04/2002WO2002027019A1 Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents
04/04/2002WO2002027018A2 Methods for identifying compounds that modulate biofilm activity
04/04/2002WO2002027017A2 Method for quantifying phosphokinase activity on proteins
04/04/2002WO2002027016A2 Gene involved in dietary sterol absorption and excretion and uses therefor
04/04/2002WO2002027015A2 Assays for identifying receptors having alterations in signaling
04/04/2002WO2002027014A2 Detection of fecal contamination
04/04/2002WO2002027012A1 Process for producing protein decomposition product
04/04/2002WO2002027008A1 Promoter sequences
04/04/2002WO2002026998A2 Hydrolases
04/04/2002WO2002026988A2 Human drug metabolizing enzymes
04/04/2002WO2002026984A2 Potassium channel interactors and uses therefor
04/04/2002WO2002026982A2 Secreted human proteins
04/04/2002WO2002026976A1 Uses of the gjb6 gene for treating certain types of alopecia including the clouston's syndrome, and for screening compounds capable of being efficient in the treatment of alopecia with genetic susceptibility
04/04/2002WO2002026962A1 Method of examining allergic disease
04/04/2002WO2002026958A2 Human neprilysin protease
04/04/2002WO2002026954A2 Truncated phosphodiesterase-7 polypeptides
04/04/2002WO2002026951A2 Oxidoreductases
04/04/2002WO2002026950A2 Transferases
04/04/2002WO2002026947A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
04/04/2002WO2002026944A2 METHODS AND COMPOSITIONS EMPLOYING A NOVEL STEAROYL-CoA DESATURASE-hSCD5
04/04/2002WO2002026929A2 Kini-3 motor protein and methods for its use
04/04/2002WO2002026834A2 32624 a novel human udp-glucuronosyl and glycosyl transferase family member and uses thereof
04/04/2002WO2002026832A1 Antibodies for human cytochrome p450 2d6
04/04/2002WO2002026825A2 G-protein coupled receptors
04/04/2002WO2002026822A2 Pumpcn compositions and uses thereof
04/04/2002WO2002026820A2 Immunomodulatory protein derived from the yaba monkey tumor virus
04/04/2002WO2002026818A2 Human nedd-1
04/04/2002WO2002026815A2 Identification of neuroblastoma tumor suppressor genes
04/04/2002WO2002026805A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
04/04/2002WO2002026771A2 Haplotypes of the scya7 gene
04/04/2002WO2002026770A2 Haplotypes of the admr gene
04/04/2002WO2002026769A2 Haplotypes of the casp5 gene
04/04/2002WO2002026768A2 Haplotypes of the por gene
04/04/2002WO2002026766A2 Haplotypes of the sstr4 gene
04/04/2002WO2002026764A2 Haplotypes of the ccr6 gene
04/04/2002WO2002026376A2 High density arrays
04/04/2002WO2002026373A1 Method and device for making a support bearing a plurality of different polynucleotide and/or peptide sequences